Literature DB >> 8590311

Species-specific activity of rat recombinant interleukin-1 beta.

C Liu1, Y Bai, D Ganea, R P Hart.   

Abstract

We have constructed expression clones for mature rat interleukin-1 beta (IL-1 beta). Using these clones, rat recombinant IL-1 beta (rrIL-1 beta) was prepared and purified by a single-step cation-exchange chromatography method. In addition, synthetic rrIL-1 beta mRNA was transcribed and used to synthesize radiolabeled 35S-rrIL-1 beta for binding studies. The rrIL-1 beta produced was demonstrated to have IL-1 bioactivity in a mouse thymocyte proliferation assay, in which it could be blocked by inclusion of human recombinant IL-1 receptor antagonist (hrIL-1Ra). Similarly, rrIL-1 beta induced LIF mRNA expression in cultured rat sympathetic ganglia. In each case, the maximal dose of rrIL-1 beta was similar to that of human IL-1 beta. However, the peak response in rat tissue was twofold higher with rat IL-1 beta than with human IL-1 beta. The expression of rrIL-1 beta provides a useful tool for studying IL-1 receptors in rat, in which human and mouse IL-1 beta have been found to bind poorly. Species-specific activity of rat IL-1 beta may correlate with compensatory ionic properties of rat IL-1 receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8590311     DOI: 10.1089/jir.1995.15.985

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  3 in total

1.  The contrasting roles of ICE family proteases and interleukin-1beta in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation.

Authors:  C M Troy; L Stefanis; A Prochiantz; L A Greene; M L Shelanski
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

2.  Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis.

Authors:  Laura Perin; Sargis Sedrakyan; Stefano Giuliani; Stefano Da Sacco; Gianni Carraro; Liron Shiri; Kevin V Lemley; Michael Rosol; Sam Wu; Anthony Atala; David Warburton; Roger E De Filippo
Journal:  PLoS One       Date:  2010-02-24       Impact factor: 3.240

3.  Neural EGFL like 1 as a potential pro-chondrogenic, anti-inflammatory dual-functional disease-modifying osteoarthritis drug.

Authors:  Chenshuang Li; Zhong Zheng; Pin Ha; Wenlu Jiang; Emily A Berthiaume; Seungjun Lee; Zane Mills; Hsinchuan Pan; Eric C Chen; Jie Jiang; Cymbeline T Culiat; Xinli Zhang; Kang Ting; Chia Soo
Journal:  Biomaterials       Date:  2019-10-12       Impact factor: 12.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.